The Patent Finder

Treatment Outcome Prediction for Lung Volume Reduction Procedures

Vida Diagnostics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,226,299Treatment Outcome Prediction for Lung Volume Reduction Procedures
In force
 · High confidence
Vida Daignostics, Inc.In force
High confidence
US 9,504,529Treatment Outcome Prediction for Lung Volume Reduction Procedures
In force
 · High confidence
Vida Diagnostics, Inc.In force
High confidence
US 11,304,756Treatment Outcome Prediction for Lung Volume Reduction Procedures
Lapsed Apr 19, 2026 on the fee record
Ended Apr 19, 2026 · Medium confidence
Vida Diagnostics, Inc.Lapsed Apr 19, 2026 on the fee recordEnded Apr 19, 2026
Medium confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Vida Diagnostics, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited